REGN icon

Regeneron Pharmaceuticals
REGN

Overview Fund Activity

670 hedge funds and large institutions have $27.1B invested in Regeneron Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 226 increasing their positions, 222 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
670
Holders Change
+27
Holders Change %
+4.2%
% of All Funds
14.95%
Holding in Top 10
15
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+15.38%
% of All Funds
0.33%
New
111
Increased
226
Reduced
222
Closed
81
Calls
$755M
Puts
$994M
Net Calls
-$239M
Net Calls Change
+$163M

Top Buyers

1
Capital World Investors
1
Capital World Investors
California
$2.63B
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2B
3
AllianceBernstein
3
AllianceBernstein
Tennessee
$470M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$63M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$134M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.12B
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$350M
3
Capital International Investors
3
Capital International Investors
California
$571M
4
Loomis, Sayles & Company
4
Loomis, Sayles & Company
Massachusetts
$1.18B
5
O
5
OrbiMed
New York
$83M
Name Holding Trade Value Shares
Change 		Shares
Change %
Franklin Resources
26
Franklin Resources
California
$217M -$27.3M -73,178 -11%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$213M -$17.1M -45,800 -7%
Goldman Sachs
28
Goldman Sachs
New York
$191M -$14.2M -37,905 -7%
Deutsche Bank
29
Deutsche Bank
Germany
$183M +$2.54M +6,798 +1%
HM
30
HealthCor Management
New York
$165M +$15.3M +40,968 +10%
Legal & General Group
31
Legal & General Group
United Kingdom
$144M +$9.15M +24,498 +7%
DCP
32
DSM Capital Partners
Florida
$139M +$18.8M +50,410 +16%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$134M +$58.6M +156,989 +78%
Renaissance Technologies
34
Renaissance Technologies
New York
$131M +$30.6M +81,800 +31%
CS
35
Candriam SCA
Luxembourg
$130M +$1.11M +2,971 +0.9%
UBS AM
36
UBS AM
Illinois
$121M +$2.27M +6,070 +2%
Neuberger Berman Group
37
Neuberger Berman Group
New York
$117M -$1.2M -3,217 -1%
Ameriprise
38
Ameriprise
Minnesota
$111M +$421K +1,128 +0.4%
Charles Schwab
39
Charles Schwab
California
$111M +$3.65M +9,766 +3%
Sumitomo Mitsui Trust Group
40
Sumitomo Mitsui Trust Group
Japan
$110M +$18.7M +51,513 +20%
First Trust Advisors
41
First Trust Advisors
Illinois
$109M +$967K +2,589 +0.9%
Wells Fargo
42
Wells Fargo
California
$97.4M +$24.4M +65,331 +33%
Swiss National Bank
43
Swiss National Bank
Switzerland
$96.7M +$1.9M +5,100 +2%
JPMorgan Chase & Co
44
JPMorgan Chase & Co
New York
$96.5M +$10.8M +28,807 +13%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$94.5M -$28.7M -76,963 -23%
PPA
46
Parametric Portfolio Associates
Washington
$88.8M +$9.25M +24,766 +12%
AQR Capital Management
47
AQR Capital Management
Connecticut
$86.4M +$17.6M +47,207 +26%
O
48
OrbiMed
New York
$83M -$64.4M -172,300 -44%
MNG
49
Manning & Napier Group
New York
$77.3M -$22.9M -61,227 -23%
Massachusetts Financial Services
50
Massachusetts Financial Services
Massachusetts
$76.5M +$11M +29,457 +17%
1
2
3 4 5